Counselors in Clinton, MT Accepting Medicare
3 Counselors found. Showing 1 - 3
 Mica Freeland Wolcott, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 19770 Swartz Creek Rd, Clinton, MT 59825 Phone: 406-540-4120 |
 Mr. Dale Parker, MA, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 12508 Cramer Creek Rd, Clinton, MT 59825 Phone: 432-266-8668 |
Dr. Kindle Lewis, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 6980 Donovan Creek Rd, Clinton, MT 59825 Phone: 406-201-9204 |
News Archive
Idera to present data from IMO-8400 preclinical studies on SLE, psoriasis at AAI meeting
Idera Pharmaceuticals, Inc. today announced that it will be presenting data from preclinical studies of its Toll-like receptor (TLR) inhibitor, IMO-8400, in models of systemic lupus erythematosus (SLE) and psoriasis, which suggest that IMO-8400 may be useful for the treatment of both indications.
Patent awarded to US Spine for its method of facet fixation using the Facet Gun and Facet Bolt
US Spine® has announced that it has been awarded patent number 7,608,094, the second in a series of patents for facet fixation. This patent provides protection to the company for its method of facet fixation using the Facet Gun™ and Facet Bolt®. Additional patents covering other devices and methods are expected to follow.
Preclinical studies show differences in healing responses to fractured and intact stent implanted in healthy, disease models
CBSET, a non-for-profit preclinical research institute dedicated to biomedical research, education and advancement of medical technologies, announced today that its scientists have published data and analyses ("Fracture in drug-eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery") that "illustrate differences in the dynamic healing responses to fractured and intact stent implanted in healthy and disease rabbit models."
Next-generation CRISPR tools and therapies improved by modified RNA guides
A new type of gene-editing tool, CRISPR-Cas13, has shown promise in RNA targeting. Previous studies have shown the tool as a potential treatment method for viral diseases, including coronavirus disease (COVID-19).
UL collaborates with renowned researchers to develop new tool that predicts chemical toxicity of substances
UL (Underwriters Laboratories), a global safety science company, announced today it is entering into a relationship with world-renown toxicologists and researchers to develop a cutting-edge tool to predict the toxicity of chemicals.
› Verified 4 days ago